Navigation Links
'Oncometabolite' linked with widespread alterations in gene expression
Date:1/18/2011

A new study finds that a metabolite commonly elevated in brain cancer and leukemia may promote tumorigenesis by altering the expression of a large number of genes. New research, published by Cell Press in the January 18th issue of the journal Cancer Cell, enhances the understanding of the link between metabolic deregulation and cancer and may help to guide development of new targeted cancer therapies.

More than 75% of low grade gliomas and secondary glioblastoma multiforme (GBM), and about 20% of acute myeloid leukemia (AML), exhibit mutations in genes for isocitrate dehydrogenase (IDH1 and IDH2). The tumor-derived mutations in IDH1 and IDH2 lead to loss of normal production of α-ketoglutarate (α-KG), which is required for over 60 enzymes known as dioxygenases, and a gain in the production of 2-hydroxygulatrate (2-HG), which is found at very low levels in normal cells.

"Although 2-HG has been proposed to be an 'oncometabolite', its mechanism of action is not known," explains senior study author, Dr. Yue Xiong from the University of North Carolina at Chapel Hill. "Previous work demonstrated that 2-HG and α-KG are structurally similar, suggesting that 2-HG might interfere with the ability of α-KG to bind to and activate dioxygenases." Dr. Xiong, co-authors Dr. Kun-Liang Guan from the University of California at San Diego and Dr. Shi-min Zhao from Fudan University in Shanghai, and their colleagues designed a series of experiments to uncover how 2-HG contributes to cancer and determine the functional relationship between α-KG reduction and 2-HG elevation.

The researchers discovered that 2-HG functioned as a competitive inhibitor of multiple α-KG-dependent dioxygenases. Some of these dioxygenases regulate methylation of histones, a group of proteins that contribute to the structural organization of chromatin, and methylation of DNA. Alteration of histone and DNA methylation is likely to have a substantial impact on regulation of gene expression and, quite possibly, promote tumor growth. The researchers also showed that a cell-permeable derivative of α-KG reversed the effects of 2-HG inhibition.

"Our findings support the notion that although D-2-HG may not play a significant role in the regulation of α-KG-dependent dioxygenases in normal cells because of its low level, it could play an important role under pathological conditions in tumor cells expressing mutated IDH1 or IDH2", concludes Dr. Xiong. "We also suggest that drugs mimicking α-KG merit exploration as a therapy for tumors that harbor an IDH1 or IDH2 mutation, either alone or in combination with inhibitors to reduce the 2-HG production."


'/>"/>

Contact: Elisabeth Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. High birth weight in First Nations babies linked to a higher risk of postneonatal death
2. Too Much TV May Be Linked to Heart Attack, Death Risk
3. High dietary fat, cholesterol linked to increased risk of breast cancer
4. Secondhand television exposure linked to eating disorders
5. Violence against mothers linked to 1.8 million female infant and child deaths in India
6. Tooth Loss May Be Linked to Memory Loss
7. Vitamins C and E linked to metabolic syndrome in low-income Ecuadorians
8. Infant hydrocephalus, seasonal and linked to farm animals in Uganda
9. Risk for alcoholism linked to risk for obesity
10. Chronic Nasal Congestion May Be Linked to Severe Asthma
11. Size of Key Brain Region Linked to Size of Your Social Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2020)... ... 2020 , ... Mary J's Cannabis , Kingston’s premium recreational cannabis shop, ... Consulting . , The store, which operates out of a 100-year-old house in ... locations as the company plans to expand across Canada. , “At Mary J’s ...
(Date:8/5/2020)... ... , ... Hypoglycemia (low blood glucose levels) in hospitalized patients ... even death. A researcher at the VA Maryland Health Care System, conducted the ... the use of continuous glucose monitoring devices can prevent hypoglycemia in inpatients on ...
(Date:8/5/2020)... ... August 04, 2020 , ... Total Spectrum, a ... Disorder (ASD) in Wisconsin, is delighted to announce the grand opening of their ... their newest center, Total Spectrum now proudly serves ten different locations across the ...
(Date:8/3/2020)... ... August 03, 2020 , ... The process uses needlepoint bipolar ... Amelia Arena, the Phoenix airport, the Mayo Clinic, Ramstein Air Force Base, Harvard ... Plasma Solutions (GPS), the manufacturers of the system, most viruses and other particles ...
(Date:7/31/2020)... ARLINGTON, Va. (PRWEB) , ... July 31, 2020 ... ... and CEO Steven C. Anderson issued the following statement today regarding the nation’s ... America’s pharmacies present patients and the nation with an efficient, effective and essential ...
Breaking Medicine News(10 mins):
(Date:8/7/2020)... (PRWEB) , ... August 07, 2020 , ... ... therapy services, is pleased to announce that it has partnered with Comprehensive Physical ... serving the central MA community since 1991 and has a strong reputation for ...
(Date:8/5/2020)... ... August 05, 2020 , ... Our pets mean the world to us, and lately with ... same without the warmth, joy, and comfort they bring. National Dog Day is coming up ... with love and appreciation. , Set aside some time to do what they love most, ...
(Date:8/5/2020)... ... 04, 2020 , ... Fifty six percent of older adults think we need ... a healthcare crisis like COVID-19, according to a new survey by The Senior Citizens ... for older voters this year,” says Mary Johnson, a Medicare, and Social Security policy ...
Breaking Medicine Technology: